Copyright Reports & Markets. All rights reserved.

Global 503B Compounding Pharmacies Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of 503B Compounding Pharmacies by Type
    • 1.3.1 Overview: Global 503B Compounding Pharmacies Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global 503B Compounding Pharmacies Consumption Value Market Share by Type in 2024
    • 1.3.3 Acetaminophen
    • 1.3.4 Phenylephrine
    • 1.3.5 Midazolam
    • 1.3.6 Esmolol
    • 1.3.7 Vancomycin
    • 1.3.8 Epinephrine
    • 1.3.9 Adenocaine
    • 1.3.10 Fentanyl/ Bupivacaine
    • 1.3.11 Morphine
  • 1.4 Global 503B Compounding Pharmacies Market by Application
    • 1.4.1 Overview: Global 503B Compounding Pharmacies Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 On-line
    • 1.4.3 Offline
  • 1.5 Global 503B Compounding Pharmacies Market Size & Forecast
  • 1.6 Global 503B Compounding Pharmacies Market Size and Forecast by Region
    • 1.6.1 Global 503B Compounding Pharmacies Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global 503B Compounding Pharmacies Market Size by Region, (2020-2031)
    • 1.6.3 North America 503B Compounding Pharmacies Market Size and Prospect (2020-2031)
    • 1.6.4 Europe 503B Compounding Pharmacies Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific 503B Compounding Pharmacies Market Size and Prospect (2020-2031)
    • 1.6.6 South America 503B Compounding Pharmacies Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa 503B Compounding Pharmacies Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Central Admixture Pharmacy Services
    • 2.1.1 Central Admixture Pharmacy Services Details
    • 2.1.2 Central Admixture Pharmacy Services Major Business
    • 2.1.3 Central Admixture Pharmacy Services 503B Compounding Pharmacies Product and Solutions
    • 2.1.4 Central Admixture Pharmacy Services 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Central Admixture Pharmacy Services Recent Developments and Future Plans
  • 2.2 Nephron Pharmaceuticals Corporation
    • 2.2.1 Nephron Pharmaceuticals Corporation Details
    • 2.2.2 Nephron Pharmaceuticals Corporation Major Business
    • 2.2.3 Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Product and Solutions
    • 2.2.4 Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Nephron Pharmaceuticals Corporation Recent Developments and Future Plans
  • 2.3 QuVa Pharma
    • 2.3.1 QuVa Pharma Details
    • 2.3.2 QuVa Pharma Major Business
    • 2.3.3 QuVa Pharma 503B Compounding Pharmacies Product and Solutions
    • 2.3.4 QuVa Pharma 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 QuVa Pharma Recent Developments and Future Plans
  • 2.4 Olympia Pharmacy
    • 2.4.1 Olympia Pharmacy Details
    • 2.4.2 Olympia Pharmacy Major Business
    • 2.4.3 Olympia Pharmacy 503B Compounding Pharmacies Product and Solutions
    • 2.4.4 Olympia Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Olympia Pharmacy Recent Developments and Future Plans
  • 2.5 ASP Cares
    • 2.5.1 ASP Cares Details
    • 2.5.2 ASP Cares Major Business
    • 2.5.3 ASP Cares 503B Compounding Pharmacies Product and Solutions
    • 2.5.4 ASP Cares 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 ASP Cares Recent Developments and Future Plans
  • 2.6 Fagron Compounding Pharmacies
    • 2.6.1 Fagron Compounding Pharmacies Details
    • 2.6.2 Fagron Compounding Pharmacies Major Business
    • 2.6.3 Fagron Compounding Pharmacies 503B Compounding Pharmacies Product and Solutions
    • 2.6.4 Fagron Compounding Pharmacies 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Fagron Compounding Pharmacies Recent Developments and Future Plans
  • 2.7 Athenex, Inc.
    • 2.7.1 Athenex, Inc. Details
    • 2.7.2 Athenex, Inc. Major Business
    • 2.7.3 Athenex, Inc. 503B Compounding Pharmacies Product and Solutions
    • 2.7.4 Athenex, Inc. 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Athenex, Inc. Recent Developments and Future Plans
  • 2.8 Avella Specialty Pharmacy
    • 2.8.1 Avella Specialty Pharmacy Details
    • 2.8.2 Avella Specialty Pharmacy Major Business
    • 2.8.3 Avella Specialty Pharmacy 503B Compounding Pharmacies Product and Solutions
    • 2.8.4 Avella Specialty Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Avella Specialty Pharmacy Recent Developments and Future Plans
  • 2.9 Atlas Pharmaceuticals
    • 2.9.1 Atlas Pharmaceuticals Details
    • 2.9.2 Atlas Pharmaceuticals Major Business
    • 2.9.3 Atlas Pharmaceuticals 503B Compounding Pharmacies Product and Solutions
    • 2.9.4 Atlas Pharmaceuticals 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Atlas Pharmaceuticals Recent Developments and Future Plans
  • 2.10 Empower Pharmacy
    • 2.10.1 Empower Pharmacy Details
    • 2.10.2 Empower Pharmacy Major Business
    • 2.10.3 Empower Pharmacy 503B Compounding Pharmacies Product and Solutions
    • 2.10.4 Empower Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Empower Pharmacy Recent Developments and Future Plans
  • 2.11 Carie Boyd’S Prescription Shop
    • 2.11.1 Carie Boyd’S Prescription Shop Details
    • 2.11.2 Carie Boyd’S Prescription Shop Major Business
    • 2.11.3 Carie Boyd’S Prescription Shop 503B Compounding Pharmacies Product and Solutions
    • 2.11.4 Carie Boyd’S Prescription Shop 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Carie Boyd’S Prescription Shop Recent Developments and Future Plans
  • 2.12 Edge Pharma, Imprimis NJOF
    • 2.12.1 Edge Pharma, Imprimis NJOF Details
    • 2.12.2 Edge Pharma, Imprimis NJOF Major Business
    • 2.12.3 Edge Pharma, Imprimis NJOF 503B Compounding Pharmacies Product and Solutions
    • 2.12.4 Edge Pharma, Imprimis NJOF 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Edge Pharma, Imprimis NJOF Recent Developments and Future Plans
  • 2.13 IntegraDose Compounding services
    • 2.13.1 IntegraDose Compounding services Details
    • 2.13.2 IntegraDose Compounding services Major Business
    • 2.13.3 IntegraDose Compounding services 503B Compounding Pharmacies Product and Solutions
    • 2.13.4 IntegraDose Compounding services 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 IntegraDose Compounding services Recent Developments and Future Plans
  • 2.14 Wells Pharma of Houston, LLC
    • 2.14.1 Wells Pharma of Houston, LLC Details
    • 2.14.2 Wells Pharma of Houston, LLC Major Business
    • 2.14.3 Wells Pharma of Houston, LLC 503B Compounding Pharmacies Product and Solutions
    • 2.14.4 Wells Pharma of Houston, LLC 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Wells Pharma of Houston, LLC Recent Developments and Future Plans
  • 2.15 US Compounding Inc.
    • 2.15.1 US Compounding Inc. Details
    • 2.15.2 US Compounding Inc. Major Business
    • 2.15.3 US Compounding Inc. 503B Compounding Pharmacies Product and Solutions
    • 2.15.4 US Compounding Inc. 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 US Compounding Inc. Recent Developments and Future Plans
  • 2.16 SCA Pharma
    • 2.16.1 SCA Pharma Details
    • 2.16.2 SCA Pharma Major Business
    • 2.16.3 SCA Pharma 503B Compounding Pharmacies Product and Solutions
    • 2.16.4 SCA Pharma 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 SCA Pharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global 503B Compounding Pharmacies Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of 503B Compounding Pharmacies by Company Revenue
    • 3.2.2 Top 3 503B Compounding Pharmacies Players Market Share in 2024
    • 3.2.3 Top 6 503B Compounding Pharmacies Players Market Share in 2024
  • 3.3 503B Compounding Pharmacies Market: Overall Company Footprint Analysis
    • 3.3.1 503B Compounding Pharmacies Market: Region Footprint
    • 3.3.2 503B Compounding Pharmacies Market: Company Product Type Footprint
    • 3.3.3 503B Compounding Pharmacies Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global 503B Compounding Pharmacies Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global 503B Compounding Pharmacies Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global 503B Compounding Pharmacies Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global 503B Compounding Pharmacies Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America 503B Compounding Pharmacies Consumption Value by Type (2020-2031)
  • 6.2 North America 503B Compounding Pharmacies Market Size by Application (2020-2031)
  • 6.3 North America 503B Compounding Pharmacies Market Size by Country
    • 6.3.1 North America 503B Compounding Pharmacies Consumption Value by Country (2020-2031)
    • 6.3.2 United States 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 6.3.3 Canada 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico 503B Compounding Pharmacies Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe 503B Compounding Pharmacies Consumption Value by Type (2020-2031)
  • 7.2 Europe 503B Compounding Pharmacies Consumption Value by Application (2020-2031)
  • 7.3 Europe 503B Compounding Pharmacies Market Size by Country
    • 7.3.1 Europe 503B Compounding Pharmacies Consumption Value by Country (2020-2031)
    • 7.3.2 Germany 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 7.3.3 France 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 7.3.5 Russia 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 7.3.6 Italy 503B Compounding Pharmacies Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific 503B Compounding Pharmacies Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific 503B Compounding Pharmacies Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific 503B Compounding Pharmacies Market Size by Region
    • 8.3.1 Asia-Pacific 503B Compounding Pharmacies Consumption Value by Region (2020-2031)
    • 8.3.2 China 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 8.3.3 Japan 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 8.3.5 India 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 8.3.7 Australia 503B Compounding Pharmacies Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America 503B Compounding Pharmacies Consumption Value by Type (2020-2031)
  • 9.2 South America 503B Compounding Pharmacies Consumption Value by Application (2020-2031)
  • 9.3 South America 503B Compounding Pharmacies Market Size by Country
    • 9.3.1 South America 503B Compounding Pharmacies Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina 503B Compounding Pharmacies Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa 503B Compounding Pharmacies Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa 503B Compounding Pharmacies Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa 503B Compounding Pharmacies Market Size by Country
    • 10.3.1 Middle East & Africa 503B Compounding Pharmacies Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia 503B Compounding Pharmacies Market Size and Forecast (2020-2031)
    • 10.3.4 UAE 503B Compounding Pharmacies Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 503B Compounding Pharmacies Market Drivers
  • 11.2 503B Compounding Pharmacies Market Restraints
  • 11.3 503B Compounding Pharmacies Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 503B Compounding Pharmacies Industry Chain
  • 12.2 503B Compounding Pharmacies Upstream Analysis
  • 12.3 503B Compounding Pharmacies Midstream Analysis
  • 12.4 503B Compounding Pharmacies Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global 503B Compounding Pharmacies market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global 503B Compounding Pharmacies market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global 503B Compounding Pharmacies market size and forecasts, in consumption value ($ Million), 2020-2031
    Global 503B Compounding Pharmacies market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global 503B Compounding Pharmacies market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global 503B Compounding Pharmacies market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for 503B Compounding Pharmacies
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global 503B Compounding Pharmacies market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Central Admixture Pharmacy Services, Nephron Pharmaceuticals Corporation, QuVa Pharma, Olympia Pharmacy, ASP Cares, Fagron Compounding Pharmacies, Athenex, Inc., Avella Specialty Pharmacy, Atlas Pharmaceuticals, Empower Pharmacy, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    503B Compounding Pharmacies market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Acetaminophen
    Phenylephrine
    Midazolam
    Esmolol
    Vancomycin
    Epinephrine
    Adenocaine
    Fentanyl/ Bupivacaine
    Morphine
    Other
    Market segment by Application
    On-line
    Offline
    Market segment by players, this report covers
    Central Admixture Pharmacy Services
    Nephron Pharmaceuticals Corporation
    QuVa Pharma
    Olympia Pharmacy
    ASP Cares
    Fagron Compounding Pharmacies
    Athenex, Inc.
    Avella Specialty Pharmacy
    Atlas Pharmaceuticals
    Empower Pharmacy
    Carie Boyd’S Prescription Shop
    Edge Pharma, Imprimis NJOF
    IntegraDose Compounding services
    Wells Pharma of Houston, LLC
    US Compounding Inc.
    SCA Pharma
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe 503B Compounding Pharmacies product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of 503B Compounding Pharmacies, with revenue, gross margin, and global market share of 503B Compounding Pharmacies from 2020 to 2025.
    Chapter 3, the 503B Compounding Pharmacies competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and 503B Compounding Pharmacies market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of 503B Compounding Pharmacies.
    Chapter 13, to describe 503B Compounding Pharmacies research findings and conclusion.

    Buy now